The RAS effector BRAF is mutated in 10–15% of early-stage CRC cases (20) and ~5% of stage IV CRC cases, with mutations predominantly occurring at hotspot codon (V600E) and being mutually exclusive with RAS mutations (21). The gene discussed is BRAF; the disease is colorectal carcinoma.